Immunomedics and Alexis sign partnership agreement for vaccines against cancer and AIDS July 31, 2009
Bayer Schering Pharma developing Toll-like receptor modulators as anti-inflammatory agents July 28, 2009
Distinct mechanism of action of chimeric variants of the anti-TLR-2 antibody OPN-301 disclosed July 23, 2009
RSS